Drug intelligence / Profile preview

acetaminophen + tramadol (AGP Limited)

Development stage
Phase 4
Lead developer
AGP
Modality
Small Molecules
Administration
Oral
01

Overview

Calfina Plus is a fixed-dose combination analgesic containing acetaminophen (paracetamol) and tramadol hydrochloride. Developed and marketed by AGP, it is approved for the management of moderate to severe pain, including postoperative pain, musculoskeletal pain, backache, osteoarthritic pain, and painful diabetic peripheral neuropathy. Tramadol is a centrally acting synthetic opioid analgesic that binds to mu-opioid receptors and weakly inhibits the reuptake of norepinephrine and serotonin. Acetaminophen is a non-opiate, non-salicylate analgesic that acts centrally to reduce pain and fever. The combination of these two agents provides synergistic pain relief, allowing for lower doses of tramadol and a reduced risk of opioid-related side effects.

Brand names
Calfina Plus
Other names
acetaminophen + tramadol hydrochlorideparacetamol + tramadolparacetamol + tramadol hydrochloride
02

Targets

MOR (Mu opioid receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on acetaminophen + tramadol (AGP Limited).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + tramadol (AGP Limited).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call